Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
842.7 USD | +0.64% | +2.73% | +43.64% |
12:08pm | Jefferies Adjusts Price Target on Eli Lilly to $957 From $925 | MT |
08:15am | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 754B | |
+41.00% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+18.60% | 250B | |
+12.16% | 217B | |
-0.53% | 216B | |
+6.13% | 164B | |
+0.03% | 163B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q4 2023 Earnings Call, Feb 06, 2024